FDA Approved: COSENTYX — Original Application (Novartis Pharmaceuticals Corporation)

View source ↗

Summary

FDA approved the original Biologics License Application for Cosentyx (secukinumab) from Novartis Pharmaceuticals Corporation, establishing its initial marketing…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ankylosing Spondylitis
• Plaque Psoriasis
• Psoriatic Arthritis

Drugs mentioned

• Cosentyx (secukinumab)

Snippet

ORIG AP for COSENTYX (SECUKINUMAB)